期刊文献+

三阴性乳腺癌3.0 T磁共振的诊断价值 被引量:11

The diagnostic value of triple-negative breast cancer using 3.0 T MRI
下载PDF
导出
摘要 目的探讨三阴性乳腺癌MRI动态增强及DWI影像学特征性表现,为临床术前评估提供依据。材料与方法选取2012年8月-2014年6月间术前接受MRI检查并经手术及病理证实的乳腺癌251例,其中三阴性乳腺癌70例,非三阴性乳腺癌[ER(+)/PR(+)/HER-2(-)型]181例。比较两种病理亚型乳腺癌的MRI动态增强及DWI影像学表现并进行相应统计学分析。结果与ER(+)/PR(+)/HER-2(-)型乳腺癌比较,三阴性乳腺癌表现多为单一病灶(P=0.018),肿瘤较大(P=0.002),组织学分级较高(P<0.001);MRI动态增强病灶多表现为肿块样强化(P=0.026),分叶状(P<0.001)、边缘光滑(P=0.005)、环形强化(P<0.001)及T2WI上病变中心呈高信号(P<0.001)为其特征性表现。DWI三阴性乳腺癌的ADC均值(1.034±0.37)×10-3 mm2/s高于ER(+)/PR(+)/HER-2(-)型乳腺癌(P=0.031)。结论对乳腺癌病人术前进行MRI检查,有助于三阴性乳腺癌与ER(+)/PR(+)/HER-2(-)型乳腺癌鉴别,可成为乳腺癌术前评估主要无创检查方法之一,为临床治疗方案确定提供依据。 Objective: To invstigate the specific findings of triple-negative breast cancer (TNBC) with dynamic contrast-enhanced MRI and DWI, and to provide the reference for presurgical evaluation. Materials and Methods:Two hundred and iffty-one patients with breast cancer who underwent operation from Augest, 2012 to June, 2014 were included. Seventy patients were TNBC, while 181 patients were ER(+)/PR(+)/HER-2(-) cancer. Comparing the dynamic contrast-enhanced breast MRI and DWI imaging findings of these two subtypes and making the appropriate statistical analysis. Results:Compared to ER(+)/PR(+)/HER-2(-) tumors, TNBC cancers were presented with single (P=0.018), larger tumor size (P=0.002), higher histologic grade (P〈0.001). MRI features associated with TNBC tumors included mass enhancement (P=0.026), lobulated (P〈0.001), smooth margins (P=0.005), ring-enhancement (P〈0.001) and areas of intratumoral high T2 signal intensity (P〈0.001). Moreover, the TNBC appeared higher ADC value (P=0.031). Conclusions:Preoperative MRI is helpful in differentiating TNBC and contrast enhanced ER (+) /PR (+) /HER-2 (-) cancer. It would be one of the most important noninvasive examination methods to preoperatively evaluate the breast cancer, and provide imaging basis for clinical treatment.
作者 王琪 常晓丹
出处 《磁共振成像》 CAS CSCD 2015年第4期283-288,共6页 Chinese Journal of Magnetic Resonance Imaging
基金 大连市医学卫生科学技术计划项目(编号:卫科发2009-67)
关键词 三阴性乳腺癌 磁共振成像 扩散加权成像 Triple-negative breast cancer Magnetic resonance imaging Diffusion weighted imaging
  • 相关文献

参考文献19

  • 1Brenton JD, Carey LA, Ahmed AA, et al. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol, 2005, 23(29): 7350-7360.
  • 2Dent R, Hanna WM, Trudeau M, et al. Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat, 2009, 115(2): 423-428.
  • 3Jung SY, Kim HY, Nam BH, et al. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Res Treat, 2010, 120(3): 627-637.
  • 4Rodriguez-Pinilla SM, Sarri6 D, Honrado E, et al. Prognostic significance of basal-like phenotype and fascin expression in nodenegative invasive breast carcinomas. Clin Cancer Res, 2006, 12(5): 1533-1539.
  • 5Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 2007, 13(l 5Pt 1): 4429-4434.
  • 6Kuhl CK, Mielearek P, Klasehil S, et al. Dynamic breast MR imaging: are signal time course data useful for diferential diagnosis of enhancing lesions. Radiology, 1999, 211(1): 101-110.
  • 7Dogan BE, Tumbull LW. Imaging of triple-negative breast cancer. Ann Oncol, 2012, 23(Supp16): 23-29.
  • 8Uematsu T, Kasami M, Yuen S, et al. Triple-negation breast cancer: correlation between MR imaging and pathological findings. Radiology, 2009, 250(3): 638-647.
  • 9Elsawaf Z, Sinn HP. Triple-negative breast cancer: clinical and histological correlations. Breast Care(Basel), 2011, 6(4): 273-278.
  • 10Whitman G J, Albarracin CT, Gonzalez-Angulo AM. Triple negative breast cancer: what the radiologist needs to know. Semin Roentgenol, 2011, 46(1): 26-39.

二级参考文献27

  • 1Bouchalova K,Cizkovaa M,Cwiertkab K,et al.Triple negative breast cancer-current status and prospective treatment based on HER1 (EGFR),TOP2A and C-MYC gene assessment[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2009,153(1):13-18.
  • 2Foulkes WD,Stefansson IM,Chappuis PO,et al.Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer[J].J Natl Cancer Inst,2003,95(19):1482-1485.
  • 3Bauer KR,Brown M,Cress RD,et al.Descriptive analysis of estrogen receptor(ER)-negative,progesterone receptor (PR)-negative,and HER2-negative invasive breast cancer,the so-called triple-negative phenotype:a population-based study from the california cancer registry[J].Cancer,2007,109(9):1721-1728.
  • 4Kuhl CK,Klaschik S,Mielcarek P,et al.Do T2-weighted sequences help with the differential of enhancing lesions in dynamic breast MRI[J].J Magn Reson Imaging,1999,9(2):187-196.
  • 5Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumours[J].Nature,2000,406(6797):747-752.
  • 6Sorlie T,Perou AM,Tibshirani R,et al.Gene expression patterns of breast carcinomasdistinguish tumor subclasses with clinical implications[J].Proc Natl Acad Sci USA,2001,98(19):10869-10874.
  • 7Softie T,Tibshirani R,Parker J,et al.Repeated observation of breast tumor subtypes in independent gene expression data sets[J].PNAS,2003,100(14):8418-8423.
  • 8Slamon DJ,Leyland-Jones B,Shak S,et al.Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2[J].N Engl J Med,2001,344(11):783-792.
  • 9Rhee J,Han S,Oh D,et al.The clinicopathologic characteristics and:prognostic significance of triple-negativity in node-negative breast cancer[J].BMC Cancer,2008,23(8):307-314.
  • 10Rebecca D,Maureen T,Kathleen I,et al.Triple-negative breast cancer:clinical features and patterns of recurrence[J].Clin Cancer Res,2007,13(15):4429-4434.

共引文献43

同被引文献69

引证文献11

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部